male avatar

Chris Takimoto

Vice President of Experimental Medicine Early Development, Oncology Therapeutic Area

San Francisco, California

Work:
Employment History of Chris Takimoto

Janssen Pharmaceuticals ​

Vice President of Experimental Medicine Early Development, Oncology Therapeutic Area


Forty Seven

Chief Medical Officer


START- South Texas Accelerated Research Therapeutics

Director of Pharmacology


Gilead Sciences

Senior Vice President


Institute for Drug Development/Cancer Therapy and Research Center

Director of Pharmacology and Zachry Chair for Translational Research


IGM Biosciences Inc

Chief Medical Officer


Ortho Biotech Oncology R&D/Johnson & Johnson

Senior Director, Translational Medicine


SWOG - Leading cancer research. Together.

Chair, Early Therapeutics Committee


Tizona Therapeutics, Inc.

Member Board Of Directors


Forty Seven, Inc.

Chief Medical Officer


Janssen, Pharmaceutical Companies of Johnson and Johnson

Vice President, Experimental Medicine Early Development, Oncology Therapeutic Area


UTHSCSA

Professor of Pharmacology (Adjunct)

Schools:
Schools Attended by Chris Takimoto

Yale University


Yale University School of Medicine


Uniformed Services University


National Cancer Institute


University of California, San Francisco

Related:
Others that have worked at the same companies
Senior FP and A Manager at gilead.com

Senior Director, State Government Affairs, West at gilead.com

Senior Scientist at gilead.com

Director at its.jnj.com

Controlled Substance Metrics and Analytics Manager at its.jnj.com

Scientist at its.jnj.com

VP, Portfolio Management at start.stoh.com